Fact Sheets
Ovarian cancer is the fifth leading cause of cancer deaths among women, and causes more deaths than any other gynecologic cancer. A woman’s risk of getting ovarian cancer during her lifetime is 1 in 78.
Innovations in diagnostics and screenings can provide access to health information and can help women make informed decisions about their gynecologic health and related cancer risks.
In recognition of Ovarian Cancer Awareness Month in September, the Society for Women’s Health Research (SWHR) published the Value of Diagnostics within Women’s Health: Ovarian Cancer Fact Sheet to highlight the impact of ovarian cancer on women’s health and share information about the role of tests – like a transvaginal ultrasound, biopsy, and blood tests – on health across the lifespan.
This fact sheet is part of the Value of Diagnostics within Women’s Health Series, created to share educational information about the value of innovative diagnostics across disease states and conditions.
This material was created by the Society for Women’s Health Research (SWHR) and is intended to serve as a public educational and informative resource. This material may be cited or shared on external channels, websites, and blogs, with attribution given to SWHR, or printed and displayed in its original formatted version. SWHR encourages the sharing and reposting of its content in order to spread awareness around women’s health issues. For specific questions about sharing SWHR content, please reach out to communications@swhr.org.
SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains independence and editorial control over program development, content, and work products.